Advocacy intelligence hub — real-time data for patient organizations
Mayo Clinic — PHASE1
NRG Oncology — NA
ARCAGY/ GINECO GROUP — PHASE2, PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Malignant mixed Müllerian tumor of the ovary news →
Kathryn P Pennington
University of Alabama at Birmingham Cancer Center
📍 Birmingham, Alabama
Alison Freimund
Peter MacCallum Cancer Centre, Australia
Brenda J. Ernst
Mayo Clinic
View all Malignant mixed Müllerian tumor of the ovary specialists →